# Atara Biotherapeutics: Biotechnology, South San Francisco, United States

> Atara Biotherapeutics: Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

Source: https://millionrounds.com/startup/atara-biotherapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# Atara Biotherapeutics

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

Email

Funding reported Last round: Post-IPO Equity

Biotechnology South San Francisco, United States

Follow Atara Biotherapeutics and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fatara-biotherapeutics)

Company summary

- **Founded:** - not reported
- **Team:** - not reported
- **Funding reported:** $550K in dollars
- **Last round:** Post-IPO Equity date not reported

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Atara Biotherapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Atara Biotherapeutics raised

Funding, as reported

Reported in all **$550K** in dollars

Last round **Post-IPO Equity**

Investors listed **5**

## Founders and team

From Atara Biotherapeutics's own website: 8 on the team.

- **Jim Sesic** Senior Vice President, Regulatory Affairs
- **Kevin Sarney** Interim Chief Financial Officer
- **Brian Cherry** Director
- **Gregory A. Ciongoli** Chairman of the Board
- **James Huang** Director
- **Matthew Fust** Director, Audit Committee Chair
- **Nachi Subramanian** Director
- **William Heiden** Director, Compensation Chair

## On 2 portfolio pages

Investors who name them

- [DAG Ventures](https://millionrounds.com/fund/dag-ventures)
- [EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital)

Each firm lists Atara Biotherapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biotechnology in United States

Startups like it

- [**Sojournix** Waltham · founded 2016 *Raised*](https://millionrounds.com/company/sojournix)
- [**Receptor Life Sciences** Seattle · founded 2017 *Raised*](https://millionrounds.com/company/receptor-life-sciences)
- [**Attune Pharmaceuticals** New York · founded 2018 *Raised*](https://millionrounds.com/company/attune-pharmaceuticals)
- [**AbbVie** North Chicago · founded 2012](https://millionrounds.com/startup/abbvie-2)
- [**Grail** Menlo Park · founded 2015](https://millionrounds.com/startup/grail-3)
- [**EQRx** Cambridge · founded 2019](https://millionrounds.com/startup/eqrx)
- [**Cerevel Therapeutics** Boston · founded 2018](https://millionrounds.com/startup/cerevel-therapeutics)
- [**Royalty Pharma** New York · founded 1996](https://millionrounds.com/startup/royalty-pharma)

## Is this your company?

Add your raise, your deck and your story, and put Atara Biotherapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)